[Therapeutical effect of a new antidyspnoeic drug in the chronic obstructive pulmonary disease (author's transl)].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004155:Diphenhydramine / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000188:drug therapy; D013806:Theophylline / Q000627:therapeutic use*; D014325:Tromethamine / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D004338:Drug Combinations; D010276:Parasympatholytics; D010627:Phenethylamines; D014325:Tromethamine; D004155:Diphenhydramine; D013806:Theophylline; D011241:Prednisone
Acción terapéutica de un nuevo preparado antidisneico en la enfermedad pulmonar obstructiva crónica